FNY Partners Fund’s Merck MRK Stock Holding History

FNY Partners Fund’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-105	Closed	-$6K	–	668
2017 Q2	$6K	Buy	+105	New	+$6.39K	﹤0.01%	420

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FNY Partners Fund's MRK Position: Q3 2017 in Review

FNY Partners Fund sold out of Merck (MRK) in Q3 2017, closing a stake of 1,048 shares — an estimated $64K sold.

FNY Partners Fund first reported a position in MRK in Q4 2016 and held it in 3 quarters. The position peaked at $64K in Q2 2017. 1,924 funds tracked by Wall St. Rank hold MRK as of Q3 2017.

FNY Partners Fund reported no remaining Merck position as of Q3 2017 after selling out during the quarter.
FNY Partners Fund sold 1,048 Merck shares in Q3 2017, an estimated $64K.
FNY Partners Fund first reported a position in Merck in Q4 2016 and held it in 3 quarters.
FNY Partners Fund's Merck position peaked at $64K in Q2 2017.
1,924 funds tracked by Wall St. Rank held Merck as of Q3 2017.

Based on FNY Partners Fund's 13F filing for Q3 2017, filed 9 Nov 2017.